GleamWall
中文EN

LIVN LivaNova PLC

Electromedical & Electrotherapeutic Apparatus · Nasdaq · SEC CIK 1639691 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY11.7%
TTM net income YoY190.1%
TTM EPS YoY187.7%
Revenue 3-yr CAGR10.5%
Net income 3-yr CAGR308.9%

Margins

Gross margin67.8%
Operating margin10.7%
Net margin13.0%
FCF margin8.6%
EBITDA margin13.0%

Returns

ROE15.5%
ROA7.4%
ROIC (approx.)15.8%
Asset turnover0.57x

Leverage & solvency

Liabilities / assets49.4%
Debt / equity0.22x
Current ratio1.46x
Interest coverage4.73x

Cash quality & payout

Operating cash flow / net income1.21x
Accruals ratio-1.6%
Payout ratio—
Capex / revenue7.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$393.15M$390.59M$362.26M$360.92M$357.75M$352.52M$316.86M$321.83M
Cost of revenue$128.10M$116.92M$118.51M$121.15M$112.90M$113.54M$100.60M$107.46M
Gross profit$265.05M$273.67M$243.75M$239.77M$244.85M$238.99M$216.25M$214.37M
R&D expense$47.69M$53.66M$58.70M$52.12M$48.58M$47.19M$37.88M$43.31M
SG&A expense$154.93M$158.13M$143.57M$143.37M$138.52M$137.78M$129.15M$130.64M
Operating income$28.43M$49.48M$41.47M$42.58M$54.01M$54.18M$48.62M$37.02M
Interest expense$7.95M$7.18M$8.29M$10.86M$10.86M$14.93M$15.29M$15.77M
Pretax income$46.77M$18.48M$27.48M$27.63M$33.91M$33.32M-$315.65M$56.48M
Income tax$12.40M-$90.20M$4.34M-$3.28M$7.11M$6.15M$11.66M$589,000
Net income$34.29M$108.57M$22.29M$30.91M$26.78M$27.16M-$327.32M$55.89M
EBITDA$37.53M$58.24M$49.77M$50.13M$61.73M$61.06M$55.04M$43.44M
EPS (basic)0.621.980.41—0.490.50-6.01—
EPS (diluted)0.111.930.40—0.490.50-6.01—
Weighted avg. shares (diluted)57.37M56.27M55.94M—55.15M54.71M54.42M—
Balance sheet
Cash & equivalents$563.47M$516.62M$539.71M$635.55M$646.08M$593.64M$738.44M$723.56M
Receivables$236.37M$231.30M$229.27M$215.99M$211.58M$220.19M$202.08M$193.16M
Inventory$177.88M$172.61M$165.50M$164.70M$167.54M$165.35M$154.02M$147.57M
Current assets$1.08B$1.03B$1.01B$1.10B$1.10B$1.07B$1.17B$1.13B
PP&E, net$293.32M$273.33M$255.48M$242.60M$218.51M$195.42M$177.68M$170.26M
Goodwill$778.80M$779.14M$785.59M$792.84M$791.03M$793.37M$761.91M$750.01M
Intangibles$210.73M$217.00M$224.56M$229.96M$234.53M$239.14M$236.59M$237.29M
Total assets$2.71B$2.64B$2.52B$2.61B$2.56B$2.51B$2.56B$2.51B
Current liabilities$740.19M$707.00M$762.48M$808.07M$827.59M$827.10M$741.57M$392.12M
Short-term debt$3.90M$3.58M$2.63M$31.47M$85.44M$82.13M$79.57M$78.00M
Long-term debt$295.19M$289.91M$285.16M$345.19M$349.03M$348.49M$549.22M$549.62M
Total debt$299.09M$293.49M$287.79M$376.66M$434.47M$430.62M$628.79M$627.63M
Total liabilities$1.34B$1.32B$1.31B$1.41B$1.40B$1.38B$1.52B$1.19B
Shareholders' equity$1.37B$1.33B$1.21B$1.20B$1.16B$1.12B$1.03B$1.32B
Net debt-$264.38M-$223.13M-$251.92M-$258.89M-$211.61M-$163.02M-$109.64M-$95.93M
Shares outstanding55.09M55.05M54.90M54.65M54.61M54.59M54.52M54.35M
Cash flow statement
Operating cash flow$73.66M$66.59M$15.22M$82.40M$85.06M$62.92M$23.97M$78.71M
Capital expenditure$30.77M$31.55M$14.29M$32.23M$22.88M$15.15M$10.79M$10.41M
Free cash flow$42.89M$35.04M$926,000$50.16M$62.18M$47.77M$13.18M$68.30M
Investing cash flow-$23.11M-$31.92M-$14.58M-$30.26M-$23.06M-$8.97M-$10.63M-$10.71M
Financing cash flow-$2.92M-$56.45M-$94.25M-$62.88M-$9.37M-$208.98M-$4.42M-$3.44M
Depreciation & amortization$9.10M$8.75M$8.30M$7.55M$7.71M$6.87M$6.42M$6.42M
Stock-based compensation$14.55M$16.88M$8.27M$9.39M$9.95M$9.17M$7.78M$6.95M

Free plan shows the latest 8 periods; Pro shows all 56 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.